Rupert Dearden
Managing Director, Corporate Broking Services
Rupert has over 20 years’ experience in UK small and mid-cap Equity Sales before joining Panmure Gordon and taking the lead in the Corporate Broking Healthcare team. He has been instrumental in numerous IPOs and Secondary Placings including MaxCyte, Dianomi, Kooth, Diurnal, Animalcare and C4X Discovery. He holds long and trusted relationships with the Institutional investment community and numerous Wealth Management Groups. Previous companies include Singer Capital Markets, Charles Stanley Securities and RW Baird.